Hypoimmune, Allogeneic CD22-Directed CAR T Cells That Evade Innate and Adaptive Immune Rejection for the Treatment of Large B Cell Lymphoma Patients That Are Relapsed/Refractory to CD19-Directed CAR T Cell TherapyAdam Johnson, Terry J. Fry, Xiaomeng Hu et al.|Blood|2023Cited by 4
Routine Histological Examination of Prepuce in Pathological Phimosis: A Recommended Sustainable PracticeRamanathan Raju, Prasanna Kumar|Cureus|2025Cited by 0